Company: CHNR
Filing Date: 2025-05-15
Form Type: 424B5
Source: 0001079973-25-000830
Chunk: 66

Company: CHINA NATURAL RESOURCES INC
Filing Date: 2025-05-15
Form: 424B5
Chunk 66
---
 future the PCAOB determines it no longer can inspect or investigate completely because of a position taken by an authority in the PRC, the PCAOB will consider issuing a new determination.

Whether the PCAOB will continue
to be able to conduct inspections of our auditor is subject to substantial uncertainty and depends on a number of factors out of our,
and our auditor’s, control. A trading prohibition would substantially impair your ability to sell or purchase our common shares
when you wish to do so, and the risk and uncertainty associated with delisting would have a negative impact on the price of our common
shares.

It
may be difficult for overseas regulators to conduct investigations or collect evidence within China.

Shareholder claims or regulatory
investigations that are common in the United States generally are difficult to pursue as a matter of law or practicality in China. For
example, in China, there are significant legal and other obstacles to providing information needed for regulatory investigations or litigation
initiated outside China. Although the authorities in China may establish a regulatory cooperation mechanism with the securities regulatory
authorities of another country or region to implement cross-border supervision and administration, such cooperation with the securities
regulatory authorities in the Unities States may not be efficient in the absence of a mutual and practical cooperation mechanism. Furthermore,
according to Article 177 of the PRC Securities Law (“Article 177”), which became effective in March 2020, no overseas securities
regulator is allowed to directly conduct investigation or evidence collection activities within the territory of the PRC. While detailed
interpretation of or implementing rules under Article 177 have yet to be promulgated, the inability for an overseas securities regulator
to directly conduct investigation or evidence collection activities within China may further increase difficulties faced by you in protecting
your interests.

If
we fail to protect our intellectual property rights, it could harm our business and competitive position.

We own five patents in China
covering our wastewater treatment technology, and we rely on a combination of patent protection, trade secret laws and other methods to
protect our intellectual property rights. The process of seeking patent protection on future patents can be lengthy and expensive, our
patent applications may be rejected and our existing and future patents may be insufficient to provide us with sufficient protection or
commercial advantage. Our patents and patent applications may also be challenged, invalidated or circumvented.

Implementation of Chinese
intellectual property-related laws has historically been ineffective, primarily due to ambiguities in Chinese laws and enforcement difficulties.
Accordingly, intellectual property rights and confidentiality protections